Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Eptifibatide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 222,652Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of March 4, 2026
    Enforcement Report - Week of March 4, 2026

    04 Mar 2026

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-4-2026-46378.pdf

    FDA
    04 Mar 2026
    Share Share
    Enforcement Report - Week of June 26, 2024
    Enforcement Report - Week of June 26, 2024

    26 Jun 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-26-2024-3489.pdf

    FDA
    26 Jun 2024
    Share Share
    Avenacy Announces Launch of Eptifibatide for Injection in the U.S. Market
    Avenacy Announces Launch of Eptifibatide for Injection in the U.S. Market

    29 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240429526438/en

    BUSINESSWIRE
    29 Apr 2024
    Share Share
    Shuangcheng's Generic Eptifibatide receives Approval in the US
    Shuangcheng's Generic Eptifibatide receives Approval in the US

    07 Sep 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213081

    FDA
    07 Sep 2021
    Share Share
    Hybio's Generic Eptifibatide Receive Approval in U.S
    Hybio's Generic Eptifibatide Receive Approval in U.S

    30 Mar 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210089

    FDA
    30 Mar 2020
    Share Share
    Enforcement Report - Week of September 4, 2019
    Enforcement Report - Week of September 4, 2019

    04 Sep 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-4-2019-1567563406.pdf

    FDA
    04 Sep 2019
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.